News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
GlaxoSmithKline Axes 350 Jobs in Overhaul of Drug Research
June 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, June 11 (Reuters) - GlaxoSmithKline Plc is axing around 350 jobs in research and development as part of an ongoing restructuring programme, Europe's biggest drugmaker said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
Europe
GSK
MORE ON THIS TOPIC
Layoff Tracker
MindMaze trims Relief staff, Aardvark cuts workforce amid Prader-Willi troubles
August 13, 2026
·
83 min read
·
BioSpace Editorial Staff
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
July’s biopharma layoffs affect 466 employees, a 94% year-over-year drop
August 13, 2026
·
3 min read
·
Angela Gabriel
Job Trends
7 companies hiring in North Carolina now
August 12, 2026
·
1 min read
·
Angela Gabriel
